Press release
Neurotrophic Keratitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Oyster Point Pharma, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, ReGenTree, BRIM Biotechnology
To Know in detail about the Neurotrophic Keratitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Neurotrophic Keratitis Market Forecast
https://www.delveinsight.com/sample-request/neurotrophic-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Neurotrophic Keratitis Market Report:
• The Neurotrophic Keratitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In 2022, the total diagnosed prevalent population of Neuroblastoma (NK) across the Seven Major Markets (7MM) was approximately 102,000.
• In 2022, the overall prevalent cases of Neuroblastoma (NK) across the Seven Major Markets (7MM) amounted to approximately 138,000. These cases of Neuroblastoma in the 7MM are projected to rise over the forecast period, spanning from 2023 to 2032.
• Within the EU4 and the UK, the United Kingdom recorded the highest diagnosed prevalence of Neuroblastoma (NK) in 2022, with Germany following closely behind.
• In 2022, the combined prevalence of Neuroblastoma (NK) cases in the EU4 and the UK accounted for approximately 43% of all prevalent cases across the Seven Major Markets.
• In the US in 2021, there were around 50,300 cases of NK that were really identified
• In 2021, there were 101,500 diagnosed cases of Neurotrophic Keratitis in the 7MM as a whole
• In the US, the greatest documented prevalence and diagnosis rate of NK in the 7MM population occurred in 2021
• Key Neurotrophic Keratitis Companies: Oyster Point Pharma, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, ReGenTree, BRIM Biotechnology Inc., Dompé Farmaceutici S.p.A, Syneos Health, and others
• Key Neurotrophic Keratitis Therapies: OC-01, REC 0559, CSB-001, RGN-259, BRM424, cenegermin-bkbj, Udonitrectag, RGN-259, and others
• The Neurotrophic Keratitis epidemiology based on gender analyzed that most of the Neurotrophic Keratitis cases comprise of the female population
• The Neurotrophic Keratitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Neurotrophic Keratitis pipeline products will significantly revolutionize the Neurotrophic Keratitis market dynamics.
Get a Free sample for the Neurotrophic Keratitis Market Report:
https://www.delveinsight.com/report-store/neurotrophic-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Neurotrophic Keratitis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Neurotrophic Keratitis Epidemiology Segmentation:
The Neurotrophic Keratitis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Neurotrophic Keratitis
• Prevalent Cases of Neurotrophic Keratitis by severity
• Gender-specific Prevalence of Neurotrophic Keratitis
• Diagnosed Cases of Episodic and Chronic Neurotrophic Keratitis
Download the report to understand which factors are driving Neurotrophic Keratitis epidemiology trends @ Neurotrophic Keratitis Epidemiology Forecast
https://www.delveinsight.com/sample-request/neurotrophic-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Neurotrophic Keratitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Neurotrophic Keratitis market or expected to get launched during the study period. The analysis covers Neurotrophic Keratitis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Neurotrophic Keratitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Neurotrophic Keratitis Therapies and Key Companies
• OC-01: Oyster Point Pharma
• REC 0559: Recordati Rare Diseases/MimeTech
• CSB-001: Claris Biotherapeutics
• RGN-259: ReGenTree
• BRM424: BRIM Biotechnology Inc.
• cenegermin-bkbj: Dompé Farmaceutici S.p.A
• Udonitrectag: Syneos Health
• RGN-259: ReGenTree, LLC
Discover more about therapies set to grab major Neurotrophic Keratitis market share @ Neurotrophic Keratitis Treatment Market
https://www.delveinsight.com/sample-request/neurotrophic-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Neurotrophic Keratitis Market Strengths
• Increasing prevalence of other conditions causes neurotrophic keratitis, thereby increasing NK population.
• The development of novel molecules potentially targets epithelial healing and corneal innervation.
• Advances in biotechnology, laser and robotic treatment also aid in the treatment of Neurotrophic Keratitis.
Neurotrophic Keratitis Market Opportunities
• The recent approval of Oxervate by EMA and priority review designation approved by the USFDA will popularize the utilization of recombinant human nerve growth factors for the treatment of neurotrophic keratitis during the forecast period.
• Researchers are increasing their investments to develop and discover drugs that could potentially treat rare eye disease
Scope of the Neurotrophic Keratitis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Neurotrophic Keratitis Companies: Oyster Point Pharma, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, ReGenTree, BRIM Biotechnology Inc., Dompé Farmaceutici S.p.A, Syneos Health, and others
• Key Neurotrophic Keratitis Therapies: OC-01, REC 0559, CSB-001, RGN-259, BRM424, cenegermin-bkbj, Udonitrectag, RGN-259, and others
• Neurotrophic Keratitis Therapeutic Assessment: Neurotrophic Keratitis current marketed and Neurotrophic Keratitis emerging therapies
• Neurotrophic Keratitis Market Dynamics: Neurotrophic Keratitis market drivers and Neurotrophic Keratitis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Neurotrophic Keratitis Unmet Needs, KOL's views, Analyst's views, Neurotrophic Keratitis Market Access and Reimbursement
To know more about Neurotrophic Keratitis companies working in the treatment market, visit @ Neurotrophic Keratitis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/neurotrophic-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Neurotrophic Keratitis Market Report Introduction
2. Executive Summary for Neurotrophic Keratitis
3. SWOT analysis of Neurotrophic Keratitis
4. Neurotrophic Keratitis Patient Share (%) Overview at a Glance
5. Neurotrophic Keratitis Market Overview at a Glance
6. Neurotrophic Keratitis Disease Background and Overview
7. Neurotrophic Keratitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Neurotrophic Keratitis
9. Neurotrophic Keratitis Current Treatment and Medical Practices
10. Neurotrophic Keratitis Unmet Needs
11. Neurotrophic Keratitis Emerging Therapies
12. Neurotrophic Keratitis Market Outlook
13. Country-Wise Neurotrophic Keratitis Market Analysis (2019-2032)
14. Neurotrophic Keratitis Market Access and Reimbursement of Therapies
15. Neurotrophic Keratitis Market Drivers
16. Neurotrophic Keratitis Market Barriers
17. Neurotrophic Keratitis Appendix
18. Neurotrophic Keratitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Neurotrophic Keratitis Pipeline https://www.delveinsight.com/report-store/neurotrophic-keratitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Neurotrophic Keratitis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Neurotrophic Keratitis market. A detailed picture of the Neurotrophic Keratitis pipeline landscape is provided, which includes the disease overview and Neurotrophic Keratitis treatment guidelines.
Neurotrophic Keratitis Epidemiology https://www.delveinsight.com/report-store/neurotrophic-keratitis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Neurotrophic Keratitis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Neurotrophic Keratitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Iga Nephropathy Market
https://www.delveinsight.com/report-store/iga-nephropathy-market
DelveInsight's "IgA Nephropathy Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of the IgA Nephropathy, historical and forecasted epidemiology as well as the IgA Nephropathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, Japan, and China.
Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market
DelveInsight's "Vutrisiran Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Vutrisiran, historical and forecasted epidemiology as well as the Vutrisiran market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Gastroesophageal Reflux Disease Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
DelveInsight's "Gastroesophageal Reflux Disease (GERD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastroesophageal Reflux Disease (GERD), historical and forecasted epidemiology as well as the Gastroesophageal Reflux Disease (GERD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
DelveInsight's 'Cerebral Palsy Market Insights, Epidemiology, and Market Forecast 2032' report delivers an in-depth understanding of cerebral palsy, historical and forecasted epidemiology as well as cerebral palsy market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Granulomatosis With Polyangiitis Market
https://www.delveinsight.com/report-store/granulomatosis-with-polyangiitis-market
DelveInsight's "Granulomatosis With Polyangiitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Granulomatosis With Polyangiitis, historical and forecasted epidemiology as well as the Granulomatosis With Polyangiitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
DelveInsight's "Hemophilia A Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Hemophilia A, historical and forecasted epidemiology as well as the Hemophilia A market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurotrophic Keratitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Oyster Point Pharma, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, ReGenTree, BRIM Biotechnology here
News-ID: 3475427 • Views: …
More Releases from DelveInsight Business Research
DelveInsight Unveils Comprehensive Epidemiology Assessment of Cutaneous Squamous …
DelveInsight, a global leader in healthcare research and analytics, announces the release of its in-depth Cutaneous Squamous Cell Carcinoma (cSCC) Epidemiology Assessment, providing unparalleled insights into the prevalence of cSCC among solid organ transplant recipients across 15 countries, including the United States, key European nations, and select countries in the Asia-Pacific (APAC) region.
The newly released assessment delivers country-specific epidemiological insights aimed at guiding strategic decision-making for pharmaceutical companies, healthcare providers,…
Unlocking Market Potential: DelveInsight's Comprehensive Patent Foramen Ovale (P …
DelveInsight's Market Size & Forecast Assessment Provides Data-Driven Insights for Patient-Centric Market Expansion Strategies
DelveInsight, a leading healthcare market research and consulting firm, has released an in-depth case study highlighting its latest assessment of the Patent Foramen Ovale (PFO) Device Market across the European Union. This strategic market intelligence report provides a holistic understanding of the patient population, device market size, competitor landscape, and reimbursement scenario, equipping medical device companies with…
Global Chronic Obstructive Pulmonary Disease Treatment Devices Market Poised for …
The Chronic Obstructive Pulmonary Disease (COPD) Treatment Devices Market is set for strong expansion, projected to grow at a CAGR of 6.35% from 2025 to 2032, according to recent industry findings. This growth is primarily fueled by the increasing global prevalence of COPD, escalating exposure to tobacco smoke and air pollution, expanding screening programs, and the rapid development of next-generation respiratory devices such as portable nebulizers and smart inhalers.
The global…
CD40 Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CD40 pipeline constitutes key companies continuously working towards developing CD40 treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"CD40 Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the CD40 Market.
The CD40 Pipeline report embraces in-depth commercial and…
More Releases for Neurotrophic
Neurotrophic Keratitis Patient Pool Analysis Market Forecast to Grow at 8.2% CAG …
Introduction
Neurotrophic keratitis (NK) is a rare, degenerative corneal disease caused by impaired corneal innervation, leading to reduced or absent corneal sensitivity. This results in poor wound healing, epithelial breakdown, and in severe cases, corneal ulceration, scarring, and vision loss. Although classified as a rare disease, NK has a significant clinical impact due to its association with conditions such as herpes simplex virus (HSV) keratitis, herpes zoster ophthalmicus, diabetes, ocular surgeries,…
Neurotrophic Keratitis Treatment Market Landscape 2025: Forecast Data and Growth …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
What Is the Expected CAGR for the Neurotrophic Keratitis Treatment Market Through 2025?
The market size for treatment of neurotrophic keratitis has experienced robust growth in the last few years. The market, which was valued at $5.1 billion in 2024, is expected to reach $5.51 billion in 2025, reflecting…
Key Neurotrophic Keratitis Treatment Market Trend for 2025-2034: Innovative Drug …
What Is the Future Outlook for the Neurotrophic Keratitis Treatment Market's Size and Growth Rate?
The neurotrophic keratitis treatment market has experienced robust growth in recent years. It is forecasted to grow from $5.1 billion in 2024 to $5.51 billion in 2025, at a CAGR of 8.1%. Historical growth has been influenced by increased diagnoses, a rising number of injuries and surgical procedures, ongoing research and development efforts, and improvements in…
Advances in Neurotrophic Keratitis Treatment: Breakthroughs and Innovations
Neurotrophic keratitis is a rare and neurodegenerative disease that affects the cornea of an eye. This disease leads to reduction or loss of cornea sensitivity. It further leads to ulcer formation and ultimately corneal perforation.
Increase in special designation from the regulatory authorities is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure and upsurge in the demand for novel therapies and treatment…
Neurotrophic Keratitis Market to Register High Revenue Growth During 2019-2027
Neurotrophic Keratitis Market: Introduction
Transparency Market Research has published a new report titled, "Global Neurotrophic Keratitis Market". According to the report, the global neurotrophic keratitis market was valued at US$ 91.6 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. Rise in reported cases of keratitis, increase in research & developmental activities, surge in awareness, and rise in co-morbidities & risk factors boost…
Neurotrophic Keratitis Market Growth Set to Surge Significantly during 2019 - 20 …
Neurotrophic Keratitis Market: Introduction
Transparency Market Research has published a new report titled, "Global Neurotrophic Keratitis Market". According to the report, the global neurotrophic keratitis market was valued at US$ 91.6 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. Rise in reported cases of keratitis, increase in research & developmental activities, surge in awareness, and rise in co-morbidities & risk factors boost…
